July 7, 2020 Price forecast | 2 weeks: -3.42% | 1 month: -5.00% | 3 months: -6.10%


APRE stock forecast

Our latest prediction for Aprea Therapeutics, Inc.'s stock price was made on the July 7, 2020 when the stock price was at 34.00$.

In the short term (2weeks), APRE's stock price should underperform the market by -3.42%. During that period the price should oscillate between -12.35% and +10.68%.

In the medium term (3months), APRE's stock price should underperform the market by -6.10%. During that period the price should oscillate between -41.38% and +32.51%.

Create a solid portfolio with APRE

Add APRE to your portfolio and optimize it!


About Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wenji Bao in 2002 and is headquartered in Boston, MA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -1.61$ per share.

The book value per share is 5.90$

Aprea Therapeutics, Inc. website


Three months stock forecastJuly 7, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -37M - -34M -1.61 - - 21M 5.90 -30M - -30M